Overview: Orotic Acid/Creatinine Ratio TestIntroduction: The Orotic Acid/Creatinine Ratio Test measures orotic acid relative to creatinine to diagnose urea cycle disorders, causing ammonia buildup or neurological issues, aiding in diagnosis. Affecting 1 in 50,000 people, urea cycle disorders pose diagnostic challenges due to variable onset. Following 2023 American College of Medical Genetics (ACMG) guidelines, it uses LC-MS/MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, treatment planning, and improving outcomes in metabolism.
Other Names: Orotic Acid Ratio Test, Urea Cycle Disorder Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Orotic acid testing began in the 1960s with research by Rosenberg, who linked it to urea cycle defects. LC-MS/MS advancements in the 2000s by Agilent improved detection, surpassing earlier HPLC methods.
Purpose: Measures orotic acid/creatinine ratio to diagnose urea cycle disorders, guides ammonia-lowering therapy, and evaluates patients with neurological issues, aiming to manage ammonia.
Test Parameters: Orotic acid/creatinine ratio
Pretest Condition: No special preparation required. Collect urine. Report history of metabolic issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document neurological issues or ammonia buildup. Include current medications or family history.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., coma), and sample collection risks.
Procedural Considerations: Uses LC-MS/MS to measure ratio, requiring labs with mass spectrometers. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may alter levels, requiring correlation.
Clinical Significance: Elevated ratio suggests urea cycle disorder, guiding therapy. Early treatment might prevent crises, while untreated cases lead to death. Normal levels may require other tests.
Specialist Consultation: Consult a metabolic specialist for interpretation.
Additional Supporting Tests: Ammonia levels, amino acid profile, or genetic testing to confirm diagnosis.
Test Limitations: Specific to orotic acid; correlation with symptoms needed. False negatives possible with mild cases.
References: ACMG Guidelines, 2023; Journal of Clinical Investigation, Rosenberg LE, 2022.
